CTOs on the Move

US HIFU

www.ushifu.com

 
US HIFU is a Charlotte, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.ushifu.com
  • 801 E Morehead St Ste 201
    Charlotte, NC USA 28202
  • Phone: 704.332.4308

Executives

Name Title Contact Details

Similar Companies

Chain Drug Consortium

Chain Drug Consortium is a Boca Raton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardinal Health

Cardinal Health, Inc. (NYSE: CAH), a global health services and products company, brings scaled solutions that help our customers thrive in a changing world. We improve the cost-effectiveness of healthcare through solutions that improve the efficiency of the supply chain; optimize the process and performance of healthcare; provide clinically proven, daily use medical products and pharmaceuticals; and connect patients, providers, payers, pharmacists and manufacturers for seamless care coordination and better patient management. Backed by nearly 100 years of experience, we rank among the top 50 on the Fortune 500 and among the Fortune Global 100. We support our partners with more than 37,000 employees in nearly 60 countries worldwide.

Scribe Healthcare Technologies

Scribe Healthcare Technologies is a Lake Forest, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Allcare Medical

Allcare Medical is a Sayreville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dthera

Dthera™ Sciences (OTCQB:DTHR) is the leading digital therapeutic company focusing on the elderly. The San Diego-based, publicly traded company is working to improve the lives of seniors and individuals suffering from neurodegenerative diseases, as well as those who care for them. It has two core products: ReminX™, a commercially available consumer health product for individuals suffering from social isolation and dementia; and DTHR-ALZ, and a development-stage product that has been granted Breakthrough Device designation by the FDA for the mitigation of the symptoms of agitation and depression associated with Alzheimer`s disease.